Uncovering Unnoticed Insights on Molina Healthcare Inc (MOH)

By Kim Brooks • Wednesday, July 02 15:10 • Permanent Link

One of the losers of today's trading session was Molina Healthcare Inc. Shares of the Medical specialities company plunged -21.0%, and some investors may be wondering if its price of $241.99 would make a good entry point. Here's what you should know if you are considering this investment:

Molina Healthcare Inc has moved 3.3% over the last year, and the S&P 500 logged a change of 11.9%
MOH has an average analyst rating of buy and is -32.69% away from its mean target price of $359.49 per share
Its trailing earnings per share (EPS) is $20.71
Molina Healthcare Inc has a trailing 12 month Price to Earnings (P/E) ratio of 11.7 while the S&P 500 average is 29.3
Its forward earnings per share (EPS) is $25.71 and its forward P/E ratio is 9.4
The company has a Price to Book (P/B) ratio of 3.03 in contrast to the S&P 500's average ratio of 4.74
Molina Healthcare Inc is part of the Health Care sector, which has an average P/E ratio of 22.94 and an average P/B of 3.19
MOH has reported YOY quarterly earnings growth of 5.4% and gross profit margins of 0.1%
The company has a free cash flow of $585.37 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 21 states. The company was founded in 1980 and is headquartered in Long Beach, California.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.